We read with interest the retrospective autopsy report review of cases from a medical ICU by Tai et al (February 2001). 1 However, in regard to undiagnosed malignancies in autopsyconfirmed cases, we consider that it is difficult to accept their data from several points: 10 days of hospitalization seemed a short time to diagnose malignant tumors; Tai et al did not describe the diagnostic procedure in detail; and the patients who participated in their study appeared to be younger than average for malignancies. Thus, to investigate discrepancies between clinical diagnoses and autopsy findings in malignancies, the data of hospitals treating patients of various ages, and with not only emergent diseases but also chronic ones, may be more reliable.
Non-small Cell Lung Cancer in Very Young and Very Old Malaysian Patients

To the Editor:
We read with great interest the article by Kuo et al (February 2000) 1 on non-small cell lung cancer (NSCLC) in very young and very old patients. This, together with the paucity of information on lung cancer in very young and very old Asian patients, [2] [3] [4] has prompted us to share our data on these patients. We reviewed the clinicopathologic data of patients with histologically and/or cytologically confirmed primary lung cancer diagnosed at our medical center, a tertiary teaching hospital, from October 1991 to September 1999. Of 510 patients with NSCLC diagnosed during this period, 32 patients (6.3%) were Ͻ 40 years old (the young group) and 14 patients (2.7%) were Ͼ 80 years old (the elderly group; Table 1 ). There was no difference in the male-to-female ratio between the young, middle-aged (40 to 80 years), and elderly groups. A significantly smaller proportion of young patients smoked compared to the other two groups. Compared with the elderly group alone, the proportion of smokers in the young group was also smaller. However, this was not statistically significant (two-tailed Fisher's Exact Test, p ϭ 0.054). Adenocarcinoma was the most common cell type in all three age groups, but it was significantly more common in the young group. There was, however, no significant difference in the proportion of adenocarcinoma between the young and the elderly groups. Metastatic (stage IV) disease at presentation was significantly more frequent in the young patients. When compared with the elderly patients, a higher proportion of young patients presented with stage IV disease (two-tailed Fisher's Exact Test, p ϭ 0.010). Of the three groups, a significantly higher proportion of young patients had poorer performance status at presentation. However, there was no significant difference in the level of performance status at presentation between the young and elderly patients.
Therefore, unlike the report by Kuo et al, 1 we did not find significantly more female patients or more instances of adenocarcinoma in very young patients when compared with very old patients. Also, unlike the report by Kuo et al, 1 we found our very young patients to have more advanced disease at presentation. TNK-tPA, we recommend administration of either standarddose unfractionated heparin (5,000-U bolus followed by 1,000 U/h) (grade 1C) or weight-adjusted dosing (60-U/kg bolus [4,000 U maximum] followed by 12 U/kg/h [1,000 U/h maximum]) (grade 2C), both adjusted to maintain an APTT of 50 to 70 s."
Erratum
• Again on page 271S, section 2.2.1 should read as follows: "For patients with known or suspected heparin-induced thrombocytopenia or thrombosis who are receiving fibrinolytic therapy (either alteplase or streptokinase), we recommend administration of IV hirudin (lepirudin 0.1-mg/kg bolus followed by 0.15 mg/kg/h infusion) (grade 2A)." 
